Almont, 4 mg 98 pcs.

Bronchial asthma, Bronchospasm, Runny nose (rhinitis)

Prevention and long-term treatment of bronchial asthma in children, including:

• preventing daytime and nighttime symptoms of the disease (for children 2 years and older);
• Treatment of bronchial asthma in patients with hypersensitivity to acetylsalicylic acid (for children 6 years and older);
• preventing exercise-induced bronchospasm (for children 2 years and older).

Pease the symptoms of seasonal and year-round allergic rhinitis in children from 2 years of age.

Active ingredient

Composition

1 chewable 4 mg tablet contains:

the active ingredient:

Montelukast 4.00 mg (as montelukast sodium 4.16 mg);

Associates:

Mannitol 160.96 mg,

Microcrystalline cellulose 52.80 mg,

Hyprolose 7.20 mg,

croscarmellose sodium 7.20 mg,

Pigment Blend PB-24880 dye (lactose monohydrate 3.60 mg, iron oxide red dye 0.40 mg) 4.00 mg,

Magnesium stearate 2.40 mg,

aspartame 1.20 mg,

cherry flavoring (Silarom Cherry Flavour 1219813182) 0.08 mg.

How to take, the dosage

Interaction

Special Instructions

Contraindications

Side effects

Overdose

Similarities